Immunotherapy combinations in advanced nonsmall cell lung cancer
CURRENT OPINION IN ONCOLOGY（2021）
关键词
atezolizumab,CTLA-4 cytotoxic T-lymphocyte-associated antigen 4,durvalumab,immune checkpoint inhibitors,ipilimumab,nivolumab,pembrolizumab,programmed death 1,programmed death ligand 1,tremelimumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要